SCHEDULE 13G/A 0001641172-25-005902 0001470622 XXXXXXXX LIVE 8 Common Stock 04/29/2025 0001847345 Aspire Biopharma Holdings, Inc. 738920107 194 Candelaro Drive, #233 Humacao PR 00791 Rule 13d-1(c) Lance Friedman X1 3872386.00 0.00 3872386.00 0.00 3872386.00 N 7.92 IN Includes 2,200,886 shares of common stock held by Blackstone Capital Advisors, Inc., 1,009,000 share of common stock held by Cobra Alternative Strategies LLC, and 662,500 shares of common stock held by Thor Special Situations LLC. Aspire Biopharma Holdings, Inc. 194 Candelaro Drive, #233, Humacao, Puerto Rico, 00791 Lance Friedman 25 N Market Street, Suite 205, Jacksonville, Florida 32202 United States Y 7.92 % 3,872,386 N/A 3,872,386 N/A Y Y Y Y Y N By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11. Lance Friedman /s/ Lance Friedman 05/07/2025